InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（6 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Crystal Roger, 首席执行官. Director active across 3 companies, notably Opiant Pharmaceuticals, INC.. In total, 13 disclosures have been published. Split: 1 buy · 6 sells. Total volume traded: €245k. History available since 16 September 2021. The latest transaction was disclosed on 21 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Crystal Roger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
4,666 股Common SharesSEC:0001193125-26-271164:0
13,671 股0Common SharesSEC:0000899243-23-016423:0
37,438 股@ US$20.0068.6% 占其流量Common StockSEC:0001385508-23-000069:0
1,358 股@ US$20.262.5% 占其流量Common StockSEC:0001385508-23-000034:0
1,183 股@ US$20.202.2% 占其流量Common StockSEC:0001385508-23-000018:0
5,029 股@ US$20.209.4% 占其流量Common StockSEC:0001385508-23-000005:0
89,286 股0Common SharesSEC:0000899243-22-028728:0
2,246 股@ US$11.112.4% 占其流量Common StockSEC:0001385508-22-000109:0
6,667 股0Common StockSEC:0001385508-22-000103:0
1,995 股@ US$26.154.9% 占其流量Common StockSEC:0001385508-22-000025:0
1,058 股@ US$30.493.0% 占其流量Common StockSEC:0001385508-22-000020:0
40,000 股0Common StockSEC:0001385508-22-000008:0
100 股@ US$23.440.2% 占其流量Common Stock par value $0.001SEC:0001385508-21-000134:0
标准退出：2021年12月15日 (T+90)
13 条申报中的 13 条
About Crystal Roger
CRYSTAL ROGER is Directeur Général. He has filed 13 disclosures in total. Across the 13 recent sampled filings, purchases amount to EUR 1992 and sales to EUR 944970, with the dominant transaction type shown as sale, over the period from 2021-09-16 to 2026-06-15. The recent filings concern Opiant Pharmaceuticals, INC., Mind Medicine (MindMed) Inc., and Definium Therapeutics, Inc.
